Gergely Losonczy

Gergely Losonczy

Auto-generated profile, based on publicly available information

Gergely Losonczy

Department of Ophthalmology, Zuyderland Hospital, Eyescan BV, Sittard, The Netherlands

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 March 2020 in Ocular Immunology and Inflammation
Verified
Journal Article
Open access
MFMariann Fodor
Mariann Fodor
GVGéza Vitályos
Géza Vitályos
GLGergely Losonczy
Gergely Losonczy
ZHZiad Hassan
Ziad Hassan
DPDorottya Pásztor
Dorottya Pásztor
BKBence Lajos Kolozsvári
Bence Lajos Kolozsvári
Purpose: To find immunomediator combinations which could sensitively indicate keratoconus progression. Methods: Tear samples of 42 patients with keratoconus were collected at baseline and at the end of a one-year follow-up. The concentrations of 13 mediators were measured by CBA. Based on Pentacam HR examination, eyes were divided into a non-progressive and a progressive group. Results: At the end of the follow-up, significant differences were observed in the release of IFNγ, IL-13, IL-17A, CCL5, MMP-13 and PAI-1 between the two groups. Changes in five Pentacam parameters correlated positively with changes in IFNγ, IL-13, IL-17A, CXCL8, CCL5, TIMP-1 and t-PA. We found that tear level of IL-13 in combination with NGF can predict the progression of keratoconus with 100% specificity and 80% sensitivity. Conclusion: The findings of our longitudinal study may underscore the importance of NGF and IL-13 tear levels in the prediction of keratoconus progression.